<?xml version="1.0" encoding="UTF-8"?>
<ref id="r20">
 <label>20</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tsuji</surname>
    <given-names>BT</given-names>
   </name>
   <name>
    <surname>Pogue</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Zavascki</surname>
    <given-names>AP</given-names>
   </name>
   <name>
    <surname>Paul</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Daikos</surname>
    <given-names>GL</given-names>
   </name>
   <name>
    <surname>Forrest</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).</article-title>
  <source>Pharmacotherapy</source>. 
  <year>2019</year>;
  <volume>39</volume>(
  <issue>1</issue>):
  <fpage>10</fpage>-
  <lpage>39</lpage>. 
  <pub-id pub-id-type="doi">10.1002/phar.2209</pub-id>
  <?supplied-pmid 30710469?>
  <pub-id pub-id-type="pmid">30710469</pub-id>
 </mixed-citation>
</ref>
